Harrow, Inc.
US ˙ NasdaqGM ˙ US4158581094

Introduction

This page provides a comprehensive analysis of the known insider trading history of Boll Andrew R.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Boll Andrew R. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:HROW / Harrow, Inc. Chief Financial Officer 777,844
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Boll Andrew R.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases HROW / Harrow, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HROW / Harrow, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-12-22 HROW BOLL ANDREW R. 2,500 13.5400 2,500 13.5400 33,850 138 28.0800 36,350 107.39
2016-12-19 IMMY BOLL ANDREW R. 39,000 1.7900 39,000 1.7900 69,810

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HROW / Harrow, Inc. Insider Trades
Insider Sales HROW / Harrow, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HROW / Harrow, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HROW / Harrow, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Boll Andrew R. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-04-07 2025-04-07 4 HROW HARROW, INC.
Common Stock
F - Taxes -136,745 777,844 -14.95 23.09 -3,157,442 17,960,418
2025-04-07 2025-04-03 4 HROW HARROW, INC.
Common Stock
M - Exercise 346,500 914,589 60.99
2024-02-21 2024-02-20 4 HROW HARROW, INC.
Common stock
M - Exercise -18,480 568,089 -3.15 10.67 -197,182 6,061,510
2024-02-21 2024-02-20 4 HROW HARROW, INC.
Common stock
M - Exercise 45,000 586,569 8.31 10.67 480,150 6,258,691
2024-02-08 2024-02-07 4 HROW HARROW, INC.
Common stock
M - Exercise 7,400 541,569 1.39 7.71 57,054 4,175,497
2023-07-20 2023-07-18 4 HROW HARROW HEALTH, INC.
Common Stock
F - Taxes -136,350 534,169 -20.33 18.23 -2,485,660 9,737,901
2023-07-20 2023-07-18 4 HROW HARROW HEALTH, INC.
Common Stock
M - Exercise 346,500 670,519 106.94
2023-04-04 2023-03-31 4 HROW HARROW HEALTH, INC.
Common Stock
F - Taxes -34,442 324,019 -9.61 21.16 -728,793 6,856,242
2023-04-04 2023-03-31 4 HROW HARROW HEALTH, INC.
Common Stock
M - Exercise 90,000 358,461 33.52 6.00 540,000 2,150,766
2023-01-03 2023-01-02 4 HROW HARROW HEALTH, INC.
Common Stock
F - Taxes -9,602 268,461 -3.45 14.76 -141,726 3,962,484
2023-01-03 2023-01-02 4 HROW HARROW HEALTH, INC.
Common Stock
M - Exercise 23,000 278,063 9.02
2022-12-23 2022-12-22 4 HROW HARROW HEALTH, INC.
Common Stock
P - Purchase 2,500 255,063 0.99 13.54 33,850 3,453,553
2022-02-23 2022-02-19 4 HROW HARROW HEALTH, INC.
Restricted Stock Unit
M - Exercise -50,000 0 -100.00
2022-02-23 2022-02-19 4 HROW HARROW HEALTH, INC.
Common Stock
F - Taxes -20,605 252,563 -7.54 7.87 -162,161 1,987,671
2022-02-23 2022-02-19 4 HROW HARROW HEALTH, INC.
Common Stock
M - Exercise 50,000 273,168 22.40
2021-07-23 2021-07-23 4 HROW HARROW HEALTH, INC.
Restricted Stock Unit
A - Award 346,500 346,500
2021-04-27 2021-04-25 4 HROW HARROW HEALTH, INC.
Restricked Stock Unit
M - Exercise -127,500 0 -100.00
2021-04-27 2021-04-25 4 HROW HARROW HEALTH, INC.
Common Stock
F - Taxes -49,832 223,168 -18.25 8.26 -411,612 1,843,368
2021-04-27 2021-04-25 4 HROW HARROW HEALTH, INC.
Common Stock
M - Exercise 127,500 273,000 87.63
2021-02-26 2021-02-25 4 HROW HARROW HEALTH, INC.
Restricted Stock Unit
M - Exercise -30,000 127,500 -19.05
2021-02-26 2021-02-25 4 HROW HARROW HEALTH, INC.
Common Stock
F - Taxes -7,500 145,500 -4.90 7.68 -57,600 1,117,440
2021-02-26 2021-02-25 4 HROW HARROW HEALTH, INC.
Common Stock
M - Exercise 30,000 153,000 24.39
2021-02-23 2021-02-19 4 HROW HARROW HEALTH, INC.
Restricted Stock Unit
A - Award 45,000 45,000
2020-01-06 2020-01-02 4 HROW HARROW HEALTH, INC.
Restricted Stock Unit
A - Award -23,000 23,000 -50.00
2020-01-06 2020-01-02 4 HROW HARROW HEALTH, INC.
Option - Right to Buy
A - Award -57,000 57,000 -50.00
2020-01-06 2020-01-02 4/A HROW HARROW HEALTH, INC.
Restricted Stock Unit
A - Award 23,000 23,000
2020-01-06 2020-01-02 4/A HROW HARROW HEALTH, INC.
Option - Right to Buy
A - Award 57,000 57,000
2019-11-25 2019-11-22 4 HROW HARROW HEALTH, INC.
Purchase Warrant
X - Other -39,000 0 -100.00
2019-11-25 2019-11-22 4 HROW HARROW HEALTH, INC.
Common Stock
X - Other 39,000 123,000 46.43 1.79 69,810 220,170
2019-02-21 2019-02-19 4 HROW HARROW HEALTH, INC.
Option - Right to Buy
A - Award 50,000 50,000
2019-02-21 2019-02-19 4 HROW HARROW HEALTH, INC.
Restricted Stock Unit
A - Award 50,000 50,000
2018-02-02 2018-02-01 4 IMMY Imprimis Pharmaceuticals, Inc.
Restricted Stock Unit
M - Exercise -30,000 30,000 -50.00
2018-02-02 2018-02-01 4 IMMY Imprimis Pharmaceuticals, Inc.
Common Stock
M - Exercise 30,000 84,000 55.56 1.83 54,900 153,720
2018-01-04 2018-01-02 4 IMMY Imprimis Pharmaceuticals, Inc.
Option - Right to Buy
A - Award 50,000 50,000
2017-02-03 2017-02-01 4 IMMY Imprimis Pharmaceuticals, Inc.
Option - Right to Buy
A - Award 55,000 55,000
2016-12-21 2016-12-19 4 IMMY Imprimis Pharmaceuticals, Inc.
Purchase Warrant
P - Purchase 39,000 39,000 0.12 4,875 4,875
2016-12-21 2016-12-19 4 IMMY Imprimis Pharmaceuticals, Inc.
Common Stock
P - Purchase 39,000 54,000 260.00 1.79 69,810 96,660
2016-04-26 2016-04-25 4 IMMY Imprimis Pharmaceuticals, Inc.
Executive RSU
D - Sale to Issuer -157,500 0 -100.00
2016-04-26 2016-04-25 4 IMMY Imprimis Pharmaceuticals, Inc.
Executive RSU
A - Award 157,500 157,500
2016-04-05 2016-04-01 4 IMMY Imprimis Pharmaceuticals, Inc.
Option - Right to Buy
A - Award 60,000 60,000
2016-02-03 2016-02-01 4 IMMY Imprimis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -15,000 0 -100.00
2016-02-03 2016-02-01 4 IMMY Imprimis Pharmaceuticals, Inc.
Common Stock
M - Exercise 15,000 202,500 8.00 3.68 55,200 745,200
2015-02-02 2015-02-01 4 IMMY Imprimis Pharmaceuticals, Inc.
Common Stock
A - Award 30,000 187,500 19.05
2015-02-02 2015-02-01 4 IMMY Imprimis Pharmaceuticals, Inc.
Common Stock
A - Award 157,500 157,500
2014-02-11 2014-02-10 4 IMMY Imprimis Pharmaceuticals, Inc.
Option - Right to Buy
A - Award 7,400 7,400
2013-05-08 2013-04-01 4 IMMY Imprimis Pharmaceuticals, Inc.
OPTION RIGHT TO BUY
A - Award 90,000 90,000
2013-03-15 2012-02-28 5 IMMY Imprimis Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 15,000 15,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)